Probably more important for the pathogenesis of SCA6 is the formation of microscopic aggregation of Cav2.1, which has been demonstrated in SCA6 human Purkinje cells by using several antibodies against the Cav2.1 C-terminus [6], [13]. The gene discussed is CACNA1A; the disease is spinocerebellar ataxia type 6.